2016
DOI: 10.1016/j.lfs.2015.12.014
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(33 citation statements)
references
References 51 publications
1
32
0
Order By: Relevance
“…[74]. It was confirmed that melatonin also plays an important role in improving the antioxidant defense in MS through upregulation of sirtuin 1 (SIRT1) and its target genes for MnSOD and CAT [100]. Moreover, melatonin is selectively taken up by mitochondrial membranes, which makes it a potential therapeutic tool in treating neurodegenerative disorders [50].…”
Section: The Importance Of Antioxidants In Msmentioning
confidence: 99%
“…[74]. It was confirmed that melatonin also plays an important role in improving the antioxidant defense in MS through upregulation of sirtuin 1 (SIRT1) and its target genes for MnSOD and CAT [100]. Moreover, melatonin is selectively taken up by mitochondrial membranes, which makes it a potential therapeutic tool in treating neurodegenerative disorders [50].…”
Section: The Importance Of Antioxidants In Msmentioning
confidence: 99%
“…Similarly, MLT promoted increased CAT concentration in the models of salivary gland injury and aggression to testicular tissue by ionizing radiation in multiple sclerosis [50][51][52].…”
Section: Catalasementioning
confidence: 99%
“…In MS, melatonin levels negatively correlate with disease activity, most likely via blockade of Th17 and induction of Tr1 differentiation via Nfil3 and Erk1/2, respectively 34 . Its therapeutic potential has been demonstrated in the animal model of MS (Experimental autoimmune encephalomyelitis, EAE) 3436 and in in vitro studies using peripheral blood mononuclear cells (PBMCs) from MS patients and healthy controls, in which melatonin improves impaired antioxidant defense through upregulation of sirtuin 1 and antioxidant enzymes 37 . Given its antioxidant properties, which are relevant to neurodegeneration and demyelination 38 , melatonin might be an interesting therapeutic target for the treatment of both active and progressive stages of MS and thus worthy of further experimental and clinical study.…”
Section: Geographic Factors and Sun Exposurementioning
confidence: 99%